ARK Genomic Revolution ETF Rating $30.53 +0.99 (+3.35%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.54Holdings in ARKG have an aggregate rating of Moderate Buy based on 295 analyst ratings issued in the past year covering 25 companies (93.2% of the portfolio).ARKG Aggregate Price Target$30.53High Prediction$30.53Average Prediction$30.53Low Prediction$30.53Holdings in ARKG have an aggregate price target of $30.53 and a range of $30.53 to $30.53 covering 25 companies (93.2% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.08%CRSPCRISPR Therapeutics$49.90+2.8%3.3263 of 5 stars2.53$65.47 31.2%19Positive News8.20%TWSTTwist Bioscience$58.83+9.6%1.5099 of 5 stars2.75$56.57 -3.8%8Gap Up8.17%TEMTempus AI$46.49+1.3%3.2971 of 5 stars2.50$68.64 47.7%145.77%BEAMBeam Therapeutics$27.67+2.1%3.5052 of 5 stars2.71$46.83 69.3%14Analyst ForecastGap Down5.51%TXG10x Genomics$24.68+2.9%1.4685 of 5 stars2.20$23.17 -6.1%15Analyst Downgrade5.16%ABSIAbsci$5.09+2.8%3.6118 of 5 stars2.50$7.53 47.8%6Gap Down4.66%ILMNIllumina$144.83+2.1%3.1819 of 5 stars2.28$137.75 -4.9%184.20%NTRANatera$203.69-0.6%3.9516 of 5 stars2.79$256.60 26.0%19Positive News4.19%PSNLPersonalis$8.25+3.8%2.2529 of 5 stars2.57$11.00 33.3%7High Trading Volume4.09%NTLAIntellia Therapeutics$12.37+0.9%3.1578 of 5 stars2.35$20.25 63.7%234.00%GHGuardant Health$118.01+2.6%2.2953 of 5 stars2.86$129.00 9.3%21Analyst ForecastHigh Trading Volume3.22%CDNACareDx$21.57+2.0%1.642 of 5 stars2.00$25.00 15.9%63.13%RXRXRecursion Pharmaceuticals$3.11+5.1%3.0714 of 5 stars2.20$8.10 160.5%5Analyst Revision3.00%VCYTVeracyte$45.192.0762 of 5 stars2.38$44.83 -0.8%82.97%CMPSCompass Pathways$11.59+6.6%3.7891 of 5 stars2.92$20.58 77.6%12Options VolumeAnalyst Revision2.28%NRIXNurix Therapeutics$17.53+6.8%2.485 of 5 stars2.93$30.46 73.8%15Analyst Forecast2.23%ADPTAdaptive Biotechnologies$13.87-0.6%3.5528 of 5 stars2.63$19.57 41.1%82.18%SDGRSchrodinger$13.23+7.4%2.8073 of 5 stars2.33$20.25 53.1%91.90%ARCTArcturus Therapeutics$7.02+2.9%2.2218 of 5 stars2.67$25.44 262.5%121.83%IONSIonis Pharmaceuticals$75.78+1.0%3.4111 of 5 stars2.90$100.90 33.1%21Analyst Upgrade1.59%CERSCerus$2.74+1.9%1.8714 of 5 stars2.25$4.00 46.0%41.57%BFLYButterfly Network$4.49+2.2%2.3205 of 5 stars2.33$5.56 24.0%61.52%ATAIAtai Beckley$4.33+5.9%3.955 of 5 stars2.91$16.00 269.5%11Analyst Revision1.46%WGSGeneDx$47.33+5.8%4.3068 of 5 stars2.63$96.43 103.7%8Insider TradeHigh Trading Volume1.32%PRMEPrime Medicine$2.95+4.2%1.8344 of 5 stars2.67$7.65 159.3%6 This page (BATS:ARKG) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
